LABP(Delisted)
Landos Biopharma·NASDAQ
--
--(--)
LABP Filings
Filing Date
Form Description
Form Type
2024-06-03
Form 15-12G - Securities registration termination [Section 12(g)]
Key Events
2024-06-03 · Key Events
Form 15-12G - Securities registration termination [Section 12(g)]
2024-05-23
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Ownership
2024-05-23 · Ownership
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024-05-23
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Ownership
2024-05-23 · Ownership
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024-05-23
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Ownership
2024-05-23 · Ownership
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024-05-23
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Ownership
2024-05-23 · Ownership
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024-05-23
Form RW - Registration Withdrawal Request
2024-05-23 ·
Form RW - Registration Withdrawal Request
2024-05-23
Form 8-K - Current report
Key Events
2024-05-23 · Key Events
Form 8-K - Current report
2024-05-23
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2024-05-23 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2024-05-23
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2024-05-23 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2024-05-23
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2024-05-23 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
